New Bacteria-Based cream aims to soothe cancer drug rash
Symptom relief
Recruiting now
This study tests a cream called ATR04-484 for treating moderate to severe skin rash that can happen when taking EGFR inhibitor cancer drugs. The cream contains a specially engineered bacteria. 32 adults will apply the cream or a placebo daily for 28 days to see if it is safe and …
Phase: PHASE1, PHASE2 • Sponsor: Azitra Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC